Cardumen Capital
Herzl St 16, Tel Aviv, Israel
Overview
Cardumen Capital is a global venture capital firm and asset management company with presence in Europe and Israel that invests in world-class founders who bring the future into the present. With €250M in Assets Under Management, Cardumen Capital’s extensive portfolio encompasses tech companies and fund investments across three different strategies, with global coverage. Cardumen Capital strives to be the most active investor for both entrepreneurs and investors. Its portfolio benefits from decades of experience in the world’s most important tech ecosystems, a culture of radical collaboration and absolute availability. Cardumen Capital is backed by world-leading institutional investors
- Total investments
- 40
- Lead investments
- 12
- Investments · 12mo
- 7
- Active investors
- 6
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Rylo
Participated · Equity · Jun 2026
Rylo develops an AI-powered communication platform that delivers real-time captioning for phone calls, in-person transcription, and text-to-speech responses to improve accessibility in personal and professional settings. The platform includes features such as sentiment analysis, speaker recognition, and fraud detection, and expanded its capabilities after acquiring Sign.mt in 2025 to launch Rylo Sign for real-time sign language translation. Rylo targets both individual and enterprise users and aims to reduce dependence on third-party interpreters while improving reliability and responsiveness in high-pressure environments. The company refines its AI models based on real user feedback and emphasizes privacy and regulatory compliance. Rylo plans to invest its new funding to grow engineering, product, and commercial teams, strengthen AI research, and scale infrastructure as it pursues global expansion and broader product offerings.
- Incapto Coffee
Participated · Series B · Apr 2026
Founded in Barcelona in 2020 by Francesc Font, Bea Mesas and Joaquim Mach, Incapto operates a vertically integrated coffee-as-a-service model combining in-house roasting, connected hardware and a digital subscription platform. Its IoT-enabled machines send usage data back to the platform, which the company uses to optimise delivery timing, personalise selections across nine-plus origins, and automate reorders. Inventory is presold through subscriptions prior to roasting, and the service targets both households and office customers as an alternative to capsule systems. Incapto positions itself as a technology-enabled service company blending hardware, software and subscriptions, competing with both subscription coffee services (e.g., Pact Coffee, Trade Coffee, Bottomless) and premium machine makers (e.g., Nespresso, De'Longhi, Jura). The company has stated that the fresh-bean subscription model reduces capsule waste and can be more cost-effective than traditional capsule systems. Financially, the business has raised about €16 million to date, including the newly closed €10 million Series B.
- Brandlight
Participated · Series A · Feb 2026
Brandlight, founded in October 2024, has built a proprietary platform that tracks and analyzes billions of AI-generated signals across the customer journey, giving marketing, PR, content, and media teams clear recommendations for how to appear in AI search results and forthcoming AI-native ad formats. The system is already used by hundreds of global brands, including Fortune 500 companies such as Kimberly-Clark, LG, The Hartford, and Estée Lauder. As AI collapses discovery, media, and conversion into a single surface, Brandlight positions itself as the operating system that lets CMOs treat “AI visibility” as a dedicated budget line and measurable discipline. The product offers real-time monitoring of brand mentions on platforms like ChatGPT and Gemini, sentiment analysis, and identification of influential content sources, enabling brands to proactively influence how AI models present their narratives. With AI-native advertising emerging as a multi-trillion-dollar channel, the company plans to extend its tooling from AI search into AI ads and commerce. The newly raised capital will fund further platform development and global scaling. Although revenue figures were not disclosed, adoption by dozens of Fortune 500 firms signals strong early traction.
- constellr
Participated · Series A · Feb 2026
constellr operates a space-based platform that captures high-resolution thermal infrared data, adding a behavioural insight layer to traditional radar and optical imaging for intelligence, surveillance and reconnaissance (ISR). The company’s technology enables earlier detection and independent verification of activity in contested or deceptive environments, exemplified by recent monitoring of maritime movements near Russia’s Rybachiy nuclear submarine base. As the only proven operational provider of such data in the European Union, constellr supplies defence and security forces with the ability to uncover hidden operations, track non-cooperative assets and anticipate deployments. Funding is being directed toward expanding its satellite constellation to provide broader global coverage and to build next-generation platforms capable of sub-5-metre resolution. The firm also aims to ensure secure, sovereign control over intelligence for European and allied customers, elevating its system to full defence-grade performance. Including the latest raise, constellr has secured a total of €75 million in funding to date.
- Biographica
Participated · Seed · Jan 2026
Founded in 2022, London-based Biographica has built a crop- and trait-agnostic platform that combines large multi-modal genomic datasets, knowledge graphs, and foundation models to predict which genes causally drive desirable agronomic traits. By feeding rapid experimental results back into its models, the company claims it can identify proven gene targets 12× faster than traditional GWAS and QTL approaches while also uncovering novel targets missed by legacy methods. The technology can deliver partners either ranked target lists or experimentally validated traits ready for field trials, and has already been piloted with two of the world’s top five seed companies as well as Cibus and BASF’s vegetable-seed arm Nunhems. Commercial traction to date comes from these paid pilots and contracts rather than product sales, but early accuracy data generated inside customer pipelines served as technical validation for investors. Biographica plans to use new capital to expand its proprietary data collection, extend the platform to additional crops and traits, and deepen commercial relationships across the seed industry. Ultimately, the company positions itself as the AI layer that converts abundant genome data into actionable edits, aiming to accelerate yield improvements and climate resilience in global agriculture.